Showing results (961-970 of 1,343) with videos related to

Sort By:
Pageof 135
Acta Cirurgica Brasileira|January 27, 2009
Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine associationLeandro Guimarães Franco, Maria Clorinda Soares Fioravanti, Adilson Donizeti Damasceno, et al.
Plos One|May 7, 2014
Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastasesJosé Medina-Echeverz, Jessica Fioravanti, Nancy Díaz-Valdés, et al.
Cells|March 11, 2023
Recent Advances in the Treatment of Genetic Forms of Parkinson's Disease: Hype or Hope?Francesco Cavallieri, Rubens G Cury, Thiago Guimarães, et al.
Biomolecules|August 29, 2024
Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson's Disease: A Possible Factor Influencing Clinical Phenotype?Francesco Cavallieri, Chiara Lucchi, Sara Grisanti, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|March 29, 2011
[Meta-analysis: effectiveness of the preventive interventions in agriculture accidents]A Sancini, T Caciari, M Fioravanti, et al.
Clinical and Experimental Rheumatology|September 1, 2012
Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)L Cantarini, L Obici, G Simonini, et al.
Chemmedchem|March 26, 2024
Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem CellsFrancesco Fiorentino, Emanuele Fabbrizi, Alessia Raucci, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Pharmacological Activation of SIRT3 Modulates the Response of Cancer Cells to Acidic pHMichele Aventaggiato, Tania Arcangeli, Enza Vernucci, et al.
Molecular Microbiology|November 29, 2016
CtrA controls cell division and outer membrane composition of the pathogen Brucella abortusNayla Francis, Katy Poncin, Antonella Fioravanti, et al.
European Journal of Pharmacology|September 15, 2004
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabineGuido Bocci, Romano Danesi, Gabriele Marangoni, et al.
Pageof 135